Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Aug 21;371(8):783.
doi: 10.1056/NEJMc1407776.

Treatments for idiopathic pulmonary fibrosis

Comment

Treatments for idiopathic pulmonary fibrosis

Luca Richeldi. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
    Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR; INPULSIS Trial Investigators. Richeldi L, et al. N Engl J Med. 2014 May 29;370(22):2071-82. doi: 10.1056/NEJMoa1402584. Epub 2014 May 18. N Engl J Med. 2014. PMID: 24836310 Clinical Trial.
  • Treatments for idiopathic pulmonary fibrosis.
    Koczulla AR. Koczulla AR. N Engl J Med. 2014 Aug 21;371(8):781. doi: 10.1056/NEJMc1407776. N Engl J Med. 2014. PMID: 25140968 No abstract available.
  • Treatments for idiopathic pulmonary fibrosis.
    Izumi S, Iikura M, Sugiyama H. Izumi S, et al. N Engl J Med. 2014 Aug 21;371(8):781-2. doi: 10.1056/NEJMc1407776. N Engl J Med. 2014. PMID: 25140969 No abstract available.

MeSH terms

LinkOut - more resources